Basic science researchers at the Johns Hopkins University School of Medicine are advancing heart health research by finding ...

Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

The study indicated that increasing the population of Bacteroides vulgatus in diabetic mice contributed to the secretion of GLP-1 (glucagon-like ... a key organ in transmitting food preferences ...

As a result, semaglutide and its fellow glucagon-like peptide-1 drugs are ... So it turns out that GLP-1 drugs may be able to target and ease the low-grade local inflammation of the synovium ...

A grandmother in Cork died after vomiting so much on the drug that her blood pH balance became “profoundly” disarrayed and triggered organ failure ... The drug is a glucagon-like peptide ...

In its role in recruitment of histone methyltransferase activity, it can act as a tumor suppressor by activating transcription of antiproliferative target genes, such as those encoding a cyclin ...

Sirt3 is a notable mitochondrial autophagy target being investigated in many ongoing studies ... This accumulation causes lipotoxicity, exacerbates oxidative stress, and leads to cellular and organ ...

Liver issues, including a buildup of fat in the liver, occur before the onset of neuromuscular disease, per a study in a ...

Hormones, including glucagon, epinephrine ... and mechanisms underlying variable effects of asprosin on tissues and organs. In the future, asprosin as a therapeutic target may be utilized in clinical ...